Clinical Trials Logo

Anesthesia clinical trials

View clinical trials related to Anesthesia.

Filter by:
  • Withdrawn  
  • Page 1 ·  Next »

NCT ID: NCT05696678 Withdrawn - Postoperative Pain Clinical Trials

Improving ObsQoR-11 With Continuous Wound Infusion Versus Intrathecal Morphine After Elective Cesarean Delivery

CIVIMEC
Start date: February 2023
Phase: N/A
Study type: Interventional

The purpose of this prospective randomized double-blinded and controlled study is to evaluate the quality of recovery after elective cesarean delivery using the Obstetric Quality-of-Recovery-11 (ObsQoR-11) score at 24 hours between patients receiving intrathecal morphine (ITM group) compared to patients receiving a ropivacaine continuous wound infusion (CWI group).

NCT ID: NCT04797546 Withdrawn - Surgery Clinical Trials

Adductor Canal Block Versus Patient Controlled Analgesia, in the Surgical Stress Response for Anterior Cruciate Ligament Repair

Start date: September 2016
Phase: Phase 1
Study type: Interventional

To evaluate the surgical stress response in anterior cruciate ligament repair with an adductor canal block versus patient controlled endovenous analgesia.

NCT ID: NCT04793373 Withdrawn - Anesthesia Clinical Trials

Superiority of Epidural Placement Technique Using EpiFaith Syringe

Start date: May 15, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the impact of EpiFaith® syringe on the establishment of successful epidural labor analgesia, change of elapsed time for identification of epidural space, and learning curve of CA-1 residents.

NCT ID: NCT04344093 Withdrawn - Anesthesia Clinical Trials

Validation of a Connected Patch, an Alternative to Conventional Monitoring

Patch
Start date: December 29, 2020
Phase: N/A
Study type: Interventional

The hypothesis is that this connected patch could be used in surgical departments to detect early a cardiovascular or respiratory complication and therefore to treat it without delay. However, it has not been validated in a hospital setting; that is the purpose of this project. This step of validating the connected monitoring object is required in different places: post-interventional surveillance room that approaches a conventional hospital room, and operating room where artifacts are numerous. Validation will be done by comparing data from General Electric's conventional monitors, with data from patches.

NCT ID: NCT04172909 Withdrawn - Anxiety Clinical Trials

LEGO MRI: Decreasing the Need for Sedation, and Improving Patient Anxiety.

LEGO MRI
Start date: February 24, 2020
Phase: N/A
Study type: Interventional

The objective of the LEGO®Bricks MRI project is to study a new play-based tool for use in children preparing to undergo MRI and evaluate its ability to reduce the need for anesthesia. A randomized study design will be employed in the experimental "Child Life" (CL) group, in regard to which Child Life intervention patients will have. Age matched controls will be found retrospectively, and will be patients of the same age, undergoing their first non-contrast brain MRI with no Child Life intervention. Patients in the CL group will be prepped by a Certified Child Life Specialist with the use of one of the following 2 tools, to be randomly selected: 1. LEGO Bricks model MRI (A model of the MRI machine and adjacent control room made out of LEGO bricks) 2. Mock MRI tube (A six foot long pop-out play tunnel for children, with a diameter of around 17 inches to simulate the MRI magnet bore)

NCT ID: NCT04053179 Withdrawn - Anesthesia Clinical Trials

Validation of a Connected Patch, an Alternative to Conventional Monitoring

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

The hypothesis is that this connected patch could be used in surgical departments to detect early a cardiovascular or respiratory complication and therefore to treat it without delay. However, it has not been validated in a hospital setting; that is the purpose of this project. This step of validating the connected monitoring object is required in different places: post-interventional surveillance room that approaches a conventional hospital room, and operating room where artifacts are numerous. Validation will be done by comparing data from General Electric's conventional monitors, with data from patches.

NCT ID: NCT03974984 Withdrawn - Surgery Clinical Trials

Anesthesia and Immunological and Oxidative Stress in Relation to Abdominal Cancer Surgery

ANIMOX
Start date: June 4, 2020
Phase:
Study type: Observational

Colorectal cancer is a frequent type of cancer accounting for 600,000 deaths annually. Surgical resection remains the best treatment for long-term survival. However, studies suggest that events in the perioperative period can induce metastasis formation and tumor growth. Tumor cells are released into the blood stream during surgery and the surgical stress may create a favorable environment for dissemination of tumor cells into distant tissue. This is done by a cascade of pro-cancerous catecholamines, prostaglandins and cytokines combined with an impaired anti-cancerous cell mediated immune response. Until recently, focus on the anesthetic management of cancer patients has been limited. Relatively small alterations in the perioperative anesthetic management may play a tremendous role in tumor progression. Optimizing anesthesia to reduce the surgical stress response could improve recurrence rates and long-term outcomes for cancer patients by inhibiting perioperative metastasis formation. Regional anesthesia and amide local anesthetics are suspected to calm the immunologic storm of prostaglandins, catecholamines and cytokines when used in the perioperative phase. Furthermore, volatile inhalational anesthesia is thought to modulate the immune system in a pro-cancerous way, while propofol may have opposite effects. Many of these recent studies are statistically underpowered and susceptible to bias, and experts in cancer treatment and anesthesia have emphasized the need for further research within this specific field. In this study the investigators aim to characterize differences in the immunologic response to surgery between inhalational, total intravenous and epidural anesthesia. This will be done by analyzing blood samples obtained in the perioperative period in patients undergoing different modes of anesthesia. The Investigators will furthermore describe the quality of recovery for patients anesthetized with the different methods

NCT ID: NCT03929315 Withdrawn - Anesthesia Clinical Trials

3D OLV Training Intervention for Pediatric Anesthesia Trainees

Start date: April 5, 2023
Phase:
Study type: Observational

One lung ventilation (OLV) in neonates and children is an advanced skill that is necessary for delivery of safe and quality anesthetic care. The current model of training for OLV in the paediatric patient is composed of the apprenticeship model. Trainees learn the techniques of doing the procedure when they encounter a case that allows for it. The model of training is often inadequate for mastery of skills such as OLV as children in this population often have severe debilitating disease often requiring the most experienced anesthesiologist to perform OLV. This limits the training exposure of anesthesia trainees.

NCT ID: NCT03843411 Withdrawn - Anesthesia Clinical Trials

Mini-fluid Challenge as a Predictor of Fluid Response for Pneumoperitoneum Patient

Start date: October 2019
Phase:
Study type: Observational

The purpose of this study is to evaluate whether the change of stroke volume index(△SVI) induced by the rapid mini-fluid administration can predict fluid responsiveness in patients with pneumoperitoneum

NCT ID: NCT03751969 Withdrawn - Anesthesia Clinical Trials

A Study Evaluating the Mass Balance of Micro-dose[14C]HSK3486 Emulsion Injection in Healthy Adults

Start date: March 30, 2020
Phase: Phase 1
Study type: Interventional

This study is designed to evaluate the mass balance in healthy Chinese male subjects after receiving a single dose of intravenous [14C]HSK3486, so as to assess the overall pharmacokinetics and safety of HSK3486 in humans and provide a reference for reasonable use of this drug.